Lymphoid gene expression supports neuroprotective microglia function
NatureTL;DR
Brain immune cells called microglia can either protect against or worsen Alzheimer's disease, and scientists found that a specific protein called CD28 helps these cells stay in "protective mode" by reducing harmful brain inflammation. This discovery could lead to new treatments that boost the brain's natural defenses against Alzheimer's.
Abstract Microglia, the innate immune cells of the brain, play a defining role in the progression of Alzheimer’s disease (AD) 1 . The microglial response to amyloid plaques in AD can range from neuroprotective to neurotoxic 2 . Here we show that the protective function of microglia is governed by the transcription factor PU.1, which becomes downregulated following microglial contact with plaques. Lowering PU.1 expression in microglia reduces the severity of amyloid disease pathology in mice and is linked to the expression of immunoregulatory lymphoid receptor proteins, particularly CD28, a surface receptor that is critical for T cell activation 3,4 . Microglia-specific deficiency in CD28, which is expressed by a small subset of plaque-associated PU.1 low microglia, promotes a broad inflammatory microglial state that is associated with increased amyloid plaque load. Our findings indicate that PU.1 low CD28-expressing microglia may operate as suppressive microglia that mitigate the progression of AD by reducing the severity of neuroinflammation. This role of CD28 and potentially other lymphoid co-stimulatory and co-inhibitory receptor proteins in governing microglial responses in AD points to possible immunotherapy approaches for treating the disease by promoting protective microglial functions.
- 1Microglia brain immune cells have both protective and harmful responses to amyloid plaques in Alzheimer's disease
- 2The transcription factor PU.1 controls protective microglial function but gets turned down when microglia encounter amyloid plaques
- 3CD28, a receptor protein normally found on immune T cells, is expressed by a small subset of protective microglia near plaques
- 4Mice lacking CD28 in their microglia showed increased brain inflammation and more amyloid plaque buildup
- 5PU.1-low, CD28-expressing microglia act as suppressive cells that reduce neuroinflammation and slow Alzheimer's progression
Adversarial AI reveals mechanisms and treatments for disorders of consciousness
Imagine your brain is like a city with millions of roads and traffic systems. When you're awake and conscious, traffic flows in complex, coordinated patterns. In a coma, something has gone wrong — but we've never had a great way to figure out exactly which roads are broken or how to fix them. This study built a very smart AI that learned to tell the difference between 'awake brain' and 'coma brain' by studying hundreds of thousands of brainwave recordings. Then, like a detective, the AI was pitted against a simulated model of the brain to figure out: what changes in the brain's wiring would explain the difference? The AI figured out — on its own, without being told — that two key things go wrong in a coma: a specific circuit deep in the brain (called the basal ganglia indirect pathway) gets disrupted, and the brain's 'braking system' (inhibitory neurons) starts working too hard in the wrong places. The researchers then checked these predictions against real patient data, and both checked out. The AI also suggested that zapping a specific deep brain region with high-frequency electrical pulses might help wake people up — and early evidence from human patients supports this idea.
Gene conversion empowers natural selection in a clonal fish species
Unfortunately, the content of this research abstract could not be accessed due to paywall restrictions. Without being able to read the actual findings about gene conversion in clonal fish species, I cannot provide an accurate explanation of what the researchers discovered or why it matters.
Direct detection of an asteroid’s heliocentric deflection: The Didymos system after DART
NASA crashed a spacecraft into an asteroid moon called Dimorphos in 2022, and scientists have now measured that this impact actually nudged the entire asteroid system slightly off its path around the Sun. This is the first time humans have measurably changed how a celestial body orbits the Sun, proving that we can potentially deflect dangerous asteroids heading toward Earth.
The dynamics of AMPA receptors underlies the efficacy of ketamine in treatment resistant patients with depression
Think of your brain as having billions of tiny locks and keys. One particular lock — called the AMPA receptor — sits on brain cells and helps them talk to each other using the chemical glutamate. In people with hard-to-treat depression, this study found that those locks are less plentiful than normal, especially in emotional brain regions. When doctors gave these patients ketamine, it actually changed how many of those locks were available on the cell surface — and the bigger that change was, the better the patient felt. So ketamine isn't just temporarily numbing pain; it appears to be physically restoring a broken communication system in the brain. The scientists confirmed this by using a special brain scan (PET scan) with a radioactive tracer that literally glows where those AMPA receptor locks are located, letting them count them in real time in living people.